Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 26301-26302 [2011-11076]

Agencies

• Centers for Disease Control and Prevention
• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 76, Number 88 (Friday, May 6, 2011)]
[Notices]
[Pages 26301-26302]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-11076]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Board on Radiation and Worker Health (ABRWH or Advisory 
Board), National Institute for Occupational Safety and Health (NIOSH)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), and pursuant to the requirements of 42 
CFR 83.15(a), the Centers for Disease Control and Prevention (CDC), 
announces the following meeting of the aforementioned committee:

Board Public Meeting Times and Dates (All times are Central Time):
    8:15 a.m.-3:45 p.m., May 24, 2011.
    8:15 a.m.-5 p.m., May 25, 2011.
    8:15 a.m.-10:30 a.m., May 26, 2011.
Public Comment Times and Dates (All times are Central Time):
    6 p.m.-7 p.m.*, May 24, 2011.
    5:30 p.m.-7 p.m.*, May 25, 2011.

    Please note that the public comment periods may end prior to the 
times indicated, following the last call for comments. Members of 
the public who wish to provide public comments should plan to attend 
public comment sessions at the start times listed.
    Place: Crowne Plaza St. Louis-Downtown, 200 North 4th Street, 
St. Louis, Missouri 63102; Telephone: 314-621-8200; Fax: 314-621-
8073. The USA toll-free dial-in number is 1-866-659-0537, pass code 
9933701.
    Status: Open to the public, limited only by the space available. 
The meeting space accommodates approximately 150 people.
    Background: The Advisory Board was established under the Energy 
Employees Occupational Illness Compensation Program (EEOICP) Act of 
2000 to advise the President on a variety of policy and technical 
functions required to implement and effectively manage the new 
compensation program. Key functions of the Advisory Board include 
providing advice on the development of probability of causation 
guidelines which have been promulgated by the Department of Health 
and Human Services (HHS) as a final rule, advice on methods of dose 
reconstruction which have also been promulgated by HHS as a final 
rule, advice on the scientific validity and quality of dose 
estimation and reconstruction efforts being performed for purposes 
of the compensation program, and advice on petitions to add

[[Page 26302]]

classes of workers to the Special Exposure Cohort (SEC).
    In December 2000, the President delegated responsibility for 
funding, staffing, and operating the Advisory Board to HHS, which 
subsequently delegated this authority to CDC. NIOSH implements this 
responsibility for CDC. The charter was issued on August 3, 2001, 
renewed at appropriate intervals, and will expire on August 3, 2011.
    Purpose: This Advisory Board is charged with (a) providing 
advice to the Secretary, HHS, on the development of guidelines under 
Executive Order 13179; (b) providing advice to the Secretary, HHS, 
on the scientific validity and quality of dose reconstruction 
efforts performed for this program; and (c) upon request by the 
Secretary, HHS, advising the Secretary on whether there is a class 
of employees at any Department of Energy (DOE) facility who were 
exposed to radiation but for whom it is not feasible to estimate 
their radiation dose, and on whether there is reasonable likelihood 
that such radiation doses may have endangered the health of members 
of this class.
    Matters To Be Discussed: The agenda for the Advisory Board 
meeting includes: NIOSH Program Update; Department of Labor (DOL) 
Program Update; DOE Program Update; NIOSH Program Evaluation; HHS 
Proposed Rule to Amend Probability of Causation Guidelines Regarding 
Chronic Lymphocytic Leukemia (42 CFR pt. 81); Savannah River Site 
Work Group Update; Feed Materials Production Center Work Group 
Update; Weldon Spring Work Group Update; SEC petitions for: Piqua 
Organic Moderated Reactor (1963-1966), Sandia National Laboratory 
(1957-1962), Hanford (Plutonium Finishing Plant, 1987-1989), General 
Electric (Evendale, Ohio); SEC Petition Status Updates; Subcommittee 
and Work Group Reports; Board Work Sessions, and an Administrative 
Session.
    The agenda is subject to change as priorities dictate.
    In the event an individual cannot attend, written comments may 
be submitted in accordance with the redaction policy provided below. 
Any written comments received will be provided at the meeting and 
should be submitted to the contact person below well in advance of 
the meeting.
    Policy on Redaction of Board Meeting Transcripts (Public 
Comment): (1) If a person making a comment gives his or her name, no 
attempt will be made to redact that name. (2) NIOSH will take 
reasonable steps to ensure that individuals making public comment 
are aware of the fact that their comments (including their name, if 
provided) will appear in a transcript of the meeting posted on a 
public Web site. Such reasonable steps include: (a) A statement read 
at the start of each public comment period stating that transcripts 
will be posted and names of speakers will not be redacted; (b) A 
printed copy of the statement mentioned in (a) above will be 
displayed on the table where individuals sign up to make public 
comments; (c) A statement such as outlined in (a) above will also 
appear with the agenda for a Board Meeting when it is posted on the 
NIOSH Web site; (d) A statement such as in (a) above will appear in 
the Federal Register Notice that announces Board and Subcommittee 
meetings. (3) If an individual in making a statement reveals 
personal information (e.g., medical information) about themselves 
that information will not usually be redacted. The NIOSH Freedom of 
Information Act (FOIA) coordinator will, however, review such 
revelations in accordance with the FOIA and the Federal Advisory 
Committee Act (FACA) and if deemed appropriate, will redact such 
information. (4) All disclosures of information concerning third 
parties will be redacted. (5) If it comes to the attention of the 
Designated Federal Officer that an individual wishes to share 
information with the Board but objects to doing so in a public 
forum, the DFO will work with that individual, in accordance with 
the FACA, to find a way that the Board can hear such comments.
    Contact Person for More Information: Theodore Katz, M.P.A., 
Executive Secretary, NIOSH, CDC, 1600 Clifton Road, Mailstop E-20, 
Atlanta Georgia 30333, telephone: (513) 533-6800, toll free: 1 
(800)CDC-INFO, e-mail: dcas@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention, 
and the Agency for Toxic Substances and Disease Registry.

    Dated: April 29, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2011-11076 Filed 5-5-11; 8:45 am]
BILLING CODE 4163-18-P